Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on first line management of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Jessicca Lin as the primary speaker and Dr. T. Raja, Dr. Amit Rauthan, Dr. B. K. Smruti and many other panelists who will share the important facts associated with first line management of ALK positive lung cancer.
Starting with the case scenario of non-small cell lung cancer, Dr Jessica has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, the panel discussion will give more knowledge.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
AI-based breast cancer risk technology receives FDA breakthrough device designation
2.
Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain
3.
examining differences in the rates of breast reconstruction following mastectomies.
4.
Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases
5.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
1.
Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts
2.
The Risk Factors of Venous Thromboembolism and How to Lower Your Chances
3.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
4.
Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment
5.
Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
2.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
3.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
4.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation